These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8808252)

  • 21. Erythropoietin and renal anemia.
    Hörl WH
    Biotechnol Ther; 1991; 2(3-4):213-30. PubMed ID: 1845127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective treatment of the anaemia associated with multiple myeloma by recombinant human erythropoietin.
    Shimamoto Y; Matsuzaki M; Yamaguchi M
    Clin Lab Haematol; 1991; 13(3):311-3. PubMed ID: 1794234
    [No Abstract]   [Full Text] [Related]  

  • 23. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E; Kaeser U
    Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 25. Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin.
    Vanrenterghem Y; Vanwalleghem J
    Nephrol Dial Transplant; 1998; 13 Suppl 2():13-5. PubMed ID: 9566485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA; Salim S; Mathew T
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anemia of chronic renal failure. Overview and early erythropoietin experience.
    Paganini EP; Garcia J; Abdulhadi M; Lathim D; Giesman J; Weick JK
    Cleve Clin J Med; 1989; 56(1):79-86. PubMed ID: 2659200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
    Li WY; Chu TS; Huang JW; Wu MS; Wu KD
    J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
    Winearls CG
    Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
    Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
    An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renal anemia - an important secondary disease in renal insufficiency].
    Mayer C; Achenbach H; Stumvoll M; Fiedler G
    Internist (Berl); 2006 Mar; 47(3):233-4, 236-8, 240-1. PubMed ID: 16470356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
    Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
    Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of anaemia in chronic renal failure.
    Beer J
    Nurs Times; 1988 Nov 23-29; 84(47):55-7. PubMed ID: 3211795
    [No Abstract]   [Full Text] [Related]  

  • 39. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW; Adamson JW
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
    Winearls CG
    Drugs; 1989 Sep; 38(3):342-5. PubMed ID: 2806134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.